Looking at the current $NOVO monthly candle formation, I think we’re finally seeing the "generational buying opportunity" we’ve been waiting for. After the overblown reaction to the 2026 guidance, the monthly setup is looking incredibly constructive. ​We are currently carving out a classic Morning Star reversal at a massive structural support level (sitting on the monthly 300-MA)

The first 2 candles necessary for the formation of the ultimate bottom (trend reversal) have been formed:

Candle 1 (February 2026): This was the capitulation candle. The stock plummeted from the 340 DKK range to a monthly close near 265 DKK.

Candle 2 (March 2026): This represents the "Star." The price bottomed at 224.25 DKK (a 52-week low) before recovering slightly to close the month in a tight, indecisive range around 230 DKK. This narrow body at the bottom of a steep drop is the classic hallmark of trend exhaustion.

Candle 3 (April 2026 - \*ACTIVE\*): Currently trading at 236.75 DKK. To complete a textbook Morning Star, the April candle needs a strong bullish close—ideally above the 285 DKK level (representing a 50% retracement of the February drop).

\*\* The Pattern is Printing, not completed yet. Stay cautious!

However, the monthly chart, so far, is a textbook reversal in the making. We had the capitulation candle in February, which flushed out the weak hands. March gave us the "Star"—a perfect doji-like candle where the selling pressure completely exhausted itself at 224.25 DKK.

​Now, in April, we’re starting to see the buyers step back in. \*IF and only IF\* we can close the month strong—ideally north of 285 DKK—it confirms the Morning Star and tells us the bottom is officially in. To me, the fact that we held that 224 level despite all the noise is a massive signal.

​The 10-11 PE Valuation is a SCREAMING "Buy"!

We don’t often get to see Novo Nordisk trading at these levels. $NVO is still one of the highest-quality businesses on the planet. At the current price, the forward dividend yield has pushed toward 5%, which is practically unheard of for a growth leader like this. It created a valuation floor that the institutions should clearly start to defend.

​Fundamental Upside: While the market is obsessed with $LLY competition, they’re ignoring the sheer scale of the GLP-1 market. There are several major upcoming catalysts, which I will discuss later, and  partnerships, such as with $HIMS toward branded disdistribution, indicate that $NVO is tightening its grip on the supply chain. Once the market realizes the 2026 guidance was just a "beat and raise" setup, the rerating will be fast.

The Morning Star is currently "in the oven." The 224.25 DKK low in March is your "line in the sand." If April finishes as a strong green candle, it confirms a bottom is likely in. However, until we see a close above 285 DKK, the broader monthly trend remains bearish.

I’m staying patient here. I want to see how April closes. If we can't clear 285 DKK on volume, this might just be a bear flag in disguise.

​What do you guys think—is the 224.25 low the definitive bottom, or is this just a pit stop before another leg down? Personally, I'm 100% bullish, although I recognize (and I don't mind) that there could be another leg down or a double bottom chart formation before finally skyrocketing to 2x, 3x, 4x and more...

NOVO Monthly Chart Pattern: Potential trend reversal